ASCO® 2026 Highlights: Presenter Vignette – Emanuele Crupi

Dr. Emanuele Crupi

Emanuele Crupi

MD

MD Anderson Cancer Center

4515

Phase II study of frontline gemcitabine, 5-fluorouracil/leucovorin, and cisplatin (GemFLP) in advanced urachal and non-urachal urinary tract adenocarcinoma.